COO Stock: The Cooper Companies, Inc. Stock Price, Analysis & Insights
Get live coo stock price $69.00, comprehensive The Cooper Companies, Inc. stock analysis, charts, news, and expert forecast. Real-time coo stock data and investment insights.
Loading chart...
Company Overview
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Company Information
- CEO
- Albert G. White III
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 16000
Contact Information
- Website
- https://www.coopercos.com
- Address
- 6101 Bollinger Canyon Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 33.8)
Business Model & Strategy
The Cooper Companies, Inc. operates in the Medical - Instruments & Supplies industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Albert G. White III, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Instruments & Supplies model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
The Cooper Companies, Inc. competes in the Medical - Instruments & Supplies within the broader Healthcare. With 13.8 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, The Cooper Companies, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating The Cooper Companies, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for The Cooper Companies, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for The Cooper Companies, Inc.
- ⚠Investors should consider how The Cooper Companies, Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 33.8) requires strong growth to justify
Market Cap
13.77B
P/E Ratio
33.82
Beta
1.06
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 13.77B market capitalization
- Trading Volume: 1.68M shares traded today
- Price Range: 52-week range of $61.78 - $106.63
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates in the Medical - Instruments & Supplies industry within the Healthcare sector. With a current market capitalization of 13.77B, the company represents a significant player in its market. The stock is currently trading at $69.00 with a positivedaily change of 0.17%.
The company's 16000 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 33.82, beta of 1.06, and 52-week price range from $61.78 to $106.63when evaluating investment opportunities.
Why Invest in The Cooper Companies, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Albert G. White III
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.